Dr. John Mitsuo Nakayama, MD

  • Pittsburgh, PA
  • Gynecologic oncologist
NPI1528266483PAC ID0941437883
Medicare services, 2024
250
Medicare patients, 2024
99
Part D claims, 2024
78
Publications
23
Clinical trials
2
Practice address
320 East North Avenue, Pittsburgh, PA 15212
Practice phone
Call (412) 359-3131
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Allegheny General Hospital

Hospital · Pittsburgh, Pennsylvania

See all 9 affiliations

Find Dr. Nakayama's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. John Mitsuo Nakayama is a gynecologic oncologist in Pittsburgh, Pennsylvania

Dr. Nakayama practices at Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health.

Dr. Nakayama's NPI, 1528266483, was assigned on July 3, 2007. Dr. Nakayama graduated from John A. Burns School of Medicine in 2007. Dr. Nakayama holds Pennsylvania license MD472231.

NPI and contact details
Medicare PAC ID
0941437883
NPI enumeration date
July 3, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(412) 359-3131
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
45
Medical school graduation
2007

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. John Mitsuo Nakayama practices at Allegheny General Hospital in Pittsburgh, Pennsylvania

Dr. Nakayama's primary practice is Allegheny General Hospital, at 320 East North Avenue, Pittsburgh, PA 15212 in Allegheny County. The practice phone is (412) 359-3131.

Source: Dmand AI Affiliation Data

Dr. John Mitsuo Nakayama is affiliated with 7 sites of care and 2 medical groups

Dr. Nakayama's primary practice is Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health. Dr. Nakayama is also affiliated with West Penn Hospital. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI also links Dr. Nakayama to 2 more hospitals, 2 group practices and clinics, 1 breast imaging center and 1 medical group, each named with a free account.

See all 9 affiliations for Dr. Nakayama

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. John Mitsuo Nakayama's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nakayama practices, 7 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Allegheny General HospitalAvailable with a free account
+6 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Nakayama practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Highmark Health and 6.2K+ hospitals, with verified contacts in the same login.

Dr. John Mitsuo Nakayama is one of 81 gynecologic oncologists in Pennsylvania

Gynecologic oncology is Dr. Nakayama's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Nakayama is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Nakayama's licenses on file in 4 states: Pennsylvania, Ohio, Virginia and North Carolina.

Specialties and state licenses

  • Gynecologic oncology, PennsylvaniaPrimaryLicense MD472231 · 2020 to 2026 · taxonomy 207VX0201X
  • Obstetrics and gynecology, OhioLicense 35.123875 · 2014 to 2026 · taxonomy 207V00000X
  • Virginia licenseLicense 0116023283 · 2011 to 2014
  • North Carolina licenseLicense 142503 · 2007 to 2011

Clinical focus

Dmand AI lists hysterectomy among the conditions Dr. Nakayama treats.

Gynecologic oncologists near Dr. Nakayama

Counts of gynecologic oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. John Mitsuo Nakayama billed Medicare for 250 services in 2024

CMS data shows 250 Medicare services from Dr. Nakayama across 6 procedure codes in 2024, for 99 Medicare patients. Medicare paid $17,420 for them.

Medicare services, 2024250
Medicare patients99
Paid by Medicare$17,420
Procedure codes6

Dr. Nakayama's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1312024: 17735%
Other services
2023: 02024: 73

Where Dr. Nakayama's Medicare services took place, 2024

  • In an office23795%
  • In a facility135%

Dr. Nakayama compared with the Pennsylvania median for gynecologic oncologists, 2024

  • Dr. Nakayama
  • Pennsylvania median
Medicare services
250vs 19131% above
Medicare patients
99vs 12118% below
Part D claims
58vs 4238% above

Medians across 81 gynecologic oncologists in Pennsylvania with Dmand AI profiles that report each measure.

Dr. Nakayama's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Nakayama

Need commercial claims for Dr. Nakayama?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Nakayama and other gynecologic oncologists in Pennsylvania.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. John Mitsuo Nakayama treated 99 Medicare patients in 2024, average age 71

CMS counts 99 Medicare patients who saw Dr. Nakayama in 2024. The largest group is 65 to 74, with 63 patients. 69% of them have high blood pressure, and 66% have high cholesterol. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nakayama's median patient age at 71, with 100% women.

Medicare patients, 202499
Average age71
Average risk score1.52

Dr. Nakayama's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Chronic conditions among Dr. Nakayama's Medicare patients, 2024

  1. High blood pressure69%
  2. High cholesterol66%
  3. Arthritis48%
  4. Cancer47%
  5. Anxiety30%
  6. Diabetes28%
  7. Mood disorders25%
  8. Depression23%

Share of Medicare patients with each condition. A patient can have several.

Dr. Nakayama's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 71

Patient panel by sex, all payers

  • Women100%
  • Men0%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. John Mitsuo Nakayama wrote 78 Medicare Part D claims in 2024

In 2024, Dr. Nakayama wrote 78 Medicare Part D claims for 25 patients. 97% of them were for generic drugs. CMS names the drug for 58 of them, across 2 drugs with 11 or more claims each, at $448 in total drug cost. In 2023, CMS named 51 claims across 2 drugs.

Part D claims, 202478
Drugs named by CMS2
Total drug cost$448
Part D patients25

Dr. Nakayama's Part D claims by kind of drug, 2024

  • Generic76 claims97%
  • Brand-name and other2 claims3%

Dr. Nakayama's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 512024: 5814%

Drugs named by CMS: 2 in 2024, 2 in 2023.

See all prescribing by Dr. Nakayama

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. John Mitsuo Nakayama scored 94 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Nakayama for performance year 2024, reported through an alternative payment model (APM). Dr. Nakayama accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Nakayama's MIPS scores, performance year 2024

  • 94of 100Final score
  • 85of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find gynecologic oncologists like Dr. Nakayama by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. John Mitsuo Nakayama has 23 publications on record

Dmand AI links 23 papers to Dr. Nakayama, published from 2013 to 2024. 2014 was the busiest year, with 2. The most frequent topics are Endometrial Neoplasms, Genital Neoplasms, Female and Ovarian Neoplasms. Dr. Nakayama has published most often in Gynecol Oncol. Dr. Nakayama's most frequent co-authors are Steven E. Waggoner, MD, Linda R. Duska, MD and Bryan James Traughber, MD.

Papers23
Years published2013 to 2024

Dr. Nakayama's papers by year, 2013 to 2024

Topics Dr. Nakayama writes about most

  • Endometrial Neoplasms
  • Genital Neoplasms, Female
  • Ovarian Neoplasms
  • Chemoradiotherapy, Adjuvant
  • Chemotherapy, Adjuvant
  • COVID-19
  • Immunohistochemistry
  • SARS-CoV-2

Dr. Nakayama's most frequent co-authors

Recent publications by Dr. Nakayama

See all 23 publications and co-authors

See who Dr. Nakayama researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Nakayama works with, so you can find a warm path to the right gynecologic oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. John Mitsuo Nakayama has worked on 2 clinical trials

Dmand AI links Dr. Nakayama to 2 clinical trials. 1 is still active or recruiting.

Investigators on the most trials with Dr. Nakayama

Recent clinical trials with Dr. Nakayama

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. John Mitsuo Nakayama received $240,003 in industry payments from 2016 to 2025

CMS Open Payments shows 297 general payments to Dr. Nakayama from 19 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 48% of the total. Eisai Inc. paid the most, $69,206.

General payments to Dr. Nakayama by program year, 2016 to 2025

General payments to Dr. Nakayama by kind, 2016 to 2025

$240Kin total
  • Speaker and faculty fees$114,77948%
  • Consulting fees$67,74428%
  • Compensation for serving as faculty or as a speaker for a medical education program$24,96910%
  • Travel and lodging$21,0829%
  • Other$11,4295%

Companies that paid Dr. Nakayama the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Nakayama

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. John Mitsuo Nakayama graduated from John A. Burns School of Medicine

Dr. Nakayama graduated from John A. Burns School of Medicine in 2007.

  1. Medical schoolJohn A. Burns School of Medicine
  2. Board certified in gynecologic oncologyAmerican Board of Obstetrics and Gynecology
  3. Board certified in obstetrics & gynecologyAmerican Board of Obstetrics and Gynecology

Source: Dmand AI Professional Profile Data

Dr. John Mitsuo Nakayama accepts plans from 17 insurance carriers

Dr. Nakayama is in network with 17 carriers, including Elevance, Aetna and Highmark. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.

Plan types Dr. Nakayama accepts, by number of carriers

  1. PPO12
  2. Medicare11
  3. HMO9
  4. POS6
  5. EPO5
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. John Mitsuo Nakayama's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. John Mitsuo Nakayama

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. John Mitsuo Nakayama's NPI number?

Dr. John Mitsuo Nakayama's NPI number is 1528266483. It was assigned on July 3, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. John Mitsuo Nakayama?

Dr. John Mitsuo Nakayama is a gynecologic oncologist in Pittsburgh, Pennsylvania. The primary specialty in the NPI Registry is Gynecologic Oncology Physician (taxonomy code 207VX0201X).

Where does Dr. John Mitsuo Nakayama practice?

Dr. Nakayama practices at 320 East North Avenue, Pittsburgh, PA 15212. Dr. Nakayama's primary practice is Allegheny General Hospital in Pittsburgh, Pennsylvania, part of Highmark Health. Dmand AI also links Dr. Nakayama to 2 hospitals, 2 group practices and clinics, 1 breast imaging center and 1 medical group.

What is Dr. John Mitsuo Nakayama's office phone number?

The practice phone on file for Dr. Nakayama is (412) 359-3131.

What is Dr. John Mitsuo Nakayama's medical license number?

Dr. Nakayama holds Pennsylvania license MD472231, one of the licenses on file in 4 states.

Which states has Dr. John Mitsuo Nakayama been licensed in?

Dmand AI has state licenses on file for Dr. Nakayama in Pennsylvania (2020 to 2026), Ohio (2014 to 2026), Virginia (2011 to 2014) and North Carolina (2007 to 2011).

Which hospitals is Dr. John Mitsuo Nakayama affiliated with?

Dr. Nakayama practices at Allegheny General Hospital in Pittsburgh, Pennsylvania. Dr. Nakayama is also affiliated with West Penn Hospital. Dmand AI links Dr. Nakayama to 2 more hospitals.

What medical group is Dr. John Mitsuo Nakayama part of?

Dr. Nakayama is linked to AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI links Dr. Nakayama to 1 more medical group.

Does Dr. John Mitsuo Nakayama accept Medicare?

Yes. CMS data shows Dr. Nakayama billed Medicare for 250 services in 2024, and Dr. Nakayama accepts Medicare assignment.

What is Dr. John Mitsuo Nakayama's MIPS score?

Dr. Nakayama's MIPS final score for performance year 2024 is 94 out of 100, reported through an alternative payment model (APM).

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. John Mitsuo Nakayama see?

CMS counts 99 Medicare patients who saw Dr. Nakayama in 2024, with an average age of 71.

Is Dr. John Mitsuo Nakayama board certified?

Yes. Dr. Nakayama is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology.

What services does Dr. John Mitsuo Nakayama bill to Medicare?

In 2024, Dr. Nakayama's most billed Medicare services were medicare service (G2211), office visit, established patient (99214) and office visit, established patient (99213).

Where did Dr. John Mitsuo Nakayama go to medical school?

Dr. Nakayama graduated from John A. Burns School of Medicine in 2007.

What drugs does Dr. John Mitsuo Nakayama prescribe most?

In 2024 Medicare Part D data, Dr. Nakayama's most prescribed drugs by claims were Dexamethasone and Prochlorperazine Maleate.

Has Dr. John Mitsuo Nakayama received payments from drug or device companies?

CMS Open Payments shows $240,003 in general payments to Dr. Nakayama from 19 companies from 2016 to 2025. The largest total came from Eisai Inc.

How long has Dr. John Mitsuo Nakayama been practicing?

Dr. Nakayama graduated from medical school in 2007, 19 years ago.

Does Dr. John Mitsuo Nakayama do research?

Dmand AI links 23 publications to Dr. Nakayama, published from 2013 to 2024. Dr. Nakayama has worked on 2 clinical trials.

Who does Dr. John Mitsuo Nakayama publish with?

Dr. Nakayama's most frequent co-authors are Steven E. Waggoner, MD (5 shared papers), Linda R. Duska, MD (3 shared papers) and Bryan James Traughber, MD (3 shared papers).

What insurance does Dr. John Mitsuo Nakayama accept?

Dr. Nakayama is in network with 17 carriers, including Elevance, Aetna and Highmark. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.

Selling to gynecologic oncology practices?

See gynecologic oncologists in Pennsylvania by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)